Craft
Visterra

Visterra

Total Funding

$125.5 M

Visterra Summary

Company summary

Overview
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration. It also provides a structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry.
Type
Private
Founded
2007
HQ
Waltham, MA, US | view all locations
Website
http://visterrainc.com/
Cybersecurity rating
Sectors

Key people

  • Greg Babcock

    Greg Babcock, Vice President, Research

    • Jean L. Bender

      Jean L. Bender, Vice President, Pharmaceutical Sciences and Technology

      • Todd Curtis

        Todd Curtis, Vice President, Finance and Controller

        • Chris Kiefer

          Chris Kiefer, Chief Administrative Officer, General Counsel and Corporate Secretary

          LocationsView all

          1 location detected

          • Waltham, MA HQ

            United States

            275 2nd Ave

          News

          Footer menu